Search - tctmd.com

Displaying 181 - 200 of 812

Sort: Relevancy | Date

News Daily News

Cardiothoracic Surgeon Domenico Pagano Dies

Michael O'Riordan

October 13, 2022

News Daily News

CV Risk Factors or Preexisting CVD: What’s Worse for COVID-19?

Caitlin E. Cox

October 11, 2022

News Conference News HFSA 2022

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

L.A. McKeown

October 07, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Daily News

Food Insecurity Rose Over the Past 20 Years in Patients With CVD

Yael L. Maxwell

September 29, 2022

News Daily News

Statewide Data Spotlight Lasting Impact of Pandemic’s PCI Shortfall in 2020

Shelley Wood

September 28, 2022

News Daily News

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

Todd Neale

September 26, 2022

News Conference News TCT 2022

Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning

Shelley Wood

September 19, 2022

News Daily News

Higher Step Counts Equal Better CV Health: UK Biobank

Caitlin E. Cox

September 13, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ESC 2022

ARBs Halve Rate of Aortic Root Enlargement in Marfan: Meta-analysis

Shelley Wood

August 29, 2022

News Conference News ESC 2022

No Hints of Cognitive Defects With ARNIs in HFpEF: PERSPECTIVE

Shelley Wood

August 26, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

Worse Complications After PVI in Women Highlight Research Gaps

L.A. McKeown

August 16, 2022

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

L.A. McKeown

June 23, 2022

News Daily News

Quadruple Therapy Costs Prohibitive for Many HFrEF Patients

L.A. McKeown

June 21, 2022

News Conference News ESC Heart Failure 2022

Dapagliflozin Boosts Health Status Across LVEF Range

Shelley Wood

May 23, 2022

Advertisement

Cardiothoracic Surgeon Domenico Pagano Dies

CV Risk Factors or Preexisting CVD: What’s Worse for COVID-19?

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Food Insecurity Rose Over the Past 20 Years in Patients With CVD

Statewide Data Spotlight Lasting Impact of Pandemic’s PCI Shortfall in 2020

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning

Higher Step Counts Equal Better CV Health: UK Biobank

CV Care Around Noncardiac Surgery: New ESC Guidelines

ARBs Halve Rate of Aortic Root Enlargement in Marfan: Meta-analysis

No Hints of Cognitive Defects With ARNIs in HFpEF: PERSPECTIVE

What’s Going to Be Hot at ESC 2022?

Worse Complications After PVI in Women Highlight Research Gaps

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

Quadruple Therapy Costs Prohibitive for Many HFrEF Patients

Dapagliflozin Boosts Health Status Across LVEF Range

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content